Form D · Other Technology
CoPatient, Inc.
Boston, MA · CIK 0001592765
Offering snapshot reported Sep 18, 2014 · SEC filing
- Reported sold
- $3.6M Offering amount: $3.6M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 21, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2014 | Initial | $3,600,000 | No comparison | 9 | SEC filing |
| Nov 25, 2013 | Initial | $1,053,679 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-224946
Source: Form D, filed Sep 18, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rebecca Palm | Director, Executive |
| Katherine Vahle | Director, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
745 Atlantic Avenue 3rd Floor
Boston, MA, 02111
Boston, MA, 02111